Dr Raji Kooner - Publications

Dr Raji Kooner has contributed as a co-author to peer-reviewed studies in prostate cancer imaging, radical prostatectomy outcomes, prostate cancer biology, brachytherapy and urological oncology surgery, as well as selected proceedings contributions. PubMed-indexed studies are listed from most recent to earliest.

2026

• Prospective Comparison of ⁶⁴Copper [⁶⁴Cu]SAR-bisPSMA vs ⁶⁸Gallium [⁶⁸Ga] PSMA-11 PET/CT for Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy (Co-PSMA Trial).

  Khan S, Papa N, Kneebone A, Eade T, Ayati N, Nguyen A, Wong K, Chen J, Ho B, Idiare J, Sidhom G, Roberts MJ, Thompson J, Sharma S, Weir S, Devitt K, Kooner R, Lieng H, Rasiah K, Olphert J, de Leon J, Hruby G, Stricker P, Emmett L.

  European Urology. 2026 Mar 27 (online ahead of print). doi: 10.1016/j.eururo.2026.03.001.

  View on PubMed →

2025

• Real-world clinical outcomes of oligometastatic prostate cancer using SBRT: An Australian experience.

  Shekar S, Crumbaker M, Joshua A, Yam A, Stricker P, Yuen C, Ende D, Namdarian B, Thompson J, Kooner R, O’Neill G, Mo J, Sim HW, Hruby G, Kasraei F, Ho A, De Leon J.

  BJUI Compass. 2025 Oct 1;6(10):e70055. doi: 10.1002/bco2.70055.

  View on PubMed →

2021

• The Additive Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography Computed Tomography to Multiparametric Magnetic Resonance Imaging Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre Study.

  Emmett L, Buteau J, Papa N, Moon D, Thompson J, Roberts MJ, Rasiah K, Pattison DA, Yaxley J, Thomas P, Hutton AC, Agrawal S, Amin A, Blazevski A, Chalasani V, Ho B, Nguyen A, Liu V, Lee J, Sheehan-Dare G, Kooner R, Coughlin G, Chan L, Cusick T, Namdarian B, Kapoor J, Alghazo O, Woo HH, Lawrentschuk N, Murphy D, Hofman MS, Stricker P.

  European Urology. 2021 Dec;80(6):682-689. doi: 10.1016/j.eururo.2021.08.002.

  View on PubMed →

2019

• Diagnostic accuracy of ⁶⁸Ga-prostate-specific membrane antigen (PSMA) positron-emission tomography (PET) and multiparametric (mp)MRI to detect intermediate-grade intra-prostatic prostate cancer using whole-mount pathology: impact of the addition of ⁶⁸Ga-PSMA PET to mpMRI.

  Scheltema MJ, Chang JI, Stricker PD, van Leeuwen PJ, Nguyen QA, Ho B, Delprado W, Lee J, Thompson JE, Cusick T, Spriensma AS, Siriwardana AR, Yuen C, Kooner R, Hruby G, O’Neill G, Emmett L.

  BJU International. 2019 Nov;124 Suppl 1:42-49. doi: 10.1111/bju.14794.

  View on PubMed →

• ⁶⁸Ga-HBEDD PSMA-11 PET/CT staging prior to radical prostatectomy in prostate cancer patients: Diagnostic and predictive value for the biochemical response to surgery.

  Nandurkar R, van Leeuwen P, Stricker P, Woo H, Kooner R, Yuen C, O’Neill G, Ende D, Cusick T, Ho B, Hickey A, Emmett L.

  British Journal of Radiology. 2019 Mar;92(1095):20180667. doi: 10.1259/bjr.20180667.

  View on PubMed →

2006

• Aberrant neuropeptide Y and macrophage inhibitory cytokine-1 expression are early events in prostate cancer development and are associated with poor prognosis.

  Rasiah KK, Kench JG, Gardiner-Garden M, Biankin AV, Golovsky D, Brenner PC, Kooner R, O’Neill GF, Turner JJ, Delprado W, Lee CS, Brown DA, Breit SN, Grygiel JJ, Horvath LG, Stricker PD, Sutherland RL, Henshall SM.

  Cancer Epidemiology, Biomarkers & Prevention. 2006 Apr;15(4):711-716. doi: 10.1158/1055-9965.EPI-05-0752.

  View on PubMed →

2005

• Lower levels of nuclear beta-catenin predict for a poorer prognosis in localized prostate cancer.

  Horvath LG, Henshall SM, Lee CS, Kench JG, Golovsky D, Brenner PC, O’Neill GF, Kooner R, Stricker PD, Grygiel JJ, Sutherland RL.

  International Journal of Cancer. 2005 Jan 20;113(3):415-422. doi: 10.1002/ijc.20599.

  View on PubMed →

2004

• Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression.

  Horvath LG, Henshall SM, Kench JG, Turner JJ, Golovsky D, Brenner PC, O’Neill GF, Kooner R, Stricker PD, Grygiel JJ, Sutherland RL.

  The Prostate. 2004 May 15;59(3):234-242. doi: 10.1002/pros.10361.

  View on PubMed →

• Membranous expression of secreted frizzled-related protein 4 predicts for good prognosis in localized prostate cancer and inhibits PC3 cellular proliferation in vitro.

  Horvath LG, Henshall SM, Kench JG, Saunders DN, Lee CS, Golovsky D, Brenner PC, O’Neill GF, Kooner R, Stricker PD, Grygiel JJ, Sutherland RL.

  Clinical Cancer Research. 2004 Jan 15;10(2):615-625. doi: 10.1158/1078-0432.ccr-0707-03.

  View on PubMed →

2003

• Prognostic significance of Gleason pattern in patients with Gleason score 7 prostate carcinoma.

  Rasiah KK, Stricker PD, Haynes AM, Delprado W, Turner JJ, Golovsky D, Brenner PC, Kooner R, O’Neill GF, Grygiel JJ, Sutherland RL, Henshall SM.

  Cancer. 2003 Dec 15;98(12):2560-2565. doi: 10.1002/cncr.11850.

  View on PubMed →

• Expression of the zinc transporter ZnT4 is decreased in the progression from early prostate disease to invasive prostate cancer.

  Henshall SM, Afar DE, Rasiah KK, Horvath LG, Gish K, Caras I, Ramakrishnan V, Wong M, Jeffry U, Kench JG, Quinn DI, Turner JJ, Delprado W, Lee CS, Golovsky D, Brenner PC, O’Neill GF, Kooner R, Stricker PD, Grygiel JJ, Mack DH, Sutherland RL.

  Oncogene. 2003 Sep 4;22(38):6005-6012. doi: 10.1038/sj.onc.1206797.

  View on PubMed →

• Treatment of localized prostate cancer using a combination of high dose rate Iridium-192 brachytherapy and external beam irradiation: initial Australian experience.

  Stevens MJ, Stricker PD, Saalfeld J, Brenner PC, Kooner R, O’Neill GF, Duval PJ, Jagavkar RS, Cross P, Martland J.

  Australasian Radiology. 2003 Jun;47(2):152-160. doi: 10.1046/j.0004-8461.2003.01143.x.

  View on PubMed →

• Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy: importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion.

  Quinn DI, Henshall SM, Brenner PC, Kooner R, Golovsky D, O’Neill GF, Turner JJ, Delprado W, Grygiel JJ, Sutherland RL, Stricker PD.

  Cancer. 2003 Apr 15;97(8):1884-1893. doi: 10.1002/cncr.11263.

  View on PubMed →

2001

• Prognostic significance of pathologic features in localized prostate cancer treated with radical prostatectomy: implications for staging systems and predictive models.

  Quinn DI, Henshall SM, Haynes AM, Brenner PC, Kooner R, Golovsky D, Mathews J, O’Neill GF, Turner JJ, Delprado W, Finlayson JF, Sutherland RL, Grygiel JJ, Stricker PD.

  Journal of Clinical Oncology. 2001 Aug 15;19(16):3692-3705. doi: 10.1200/JCO.2001.19.16.3692.

  View on PubMed →

• Frequent loss of estrogen receptor-beta expression in prostate cancer.

  Horvath LG, Henshall SM, Lee CS, Head DR, Quinn DI, Makela S, Delprado W, Golovsky D, Brenner PC, O’Neill G, Kooner R, Stricker PD, Grygiel JJ, Gustafsson JA, Sutherland RL.

  Cancer Research. 2001 Jul 15;61(14):5331-5335.

  View on PubMed →

1998

• Vascular interventions during post-chemotherapy retroperitoneal lymph-node dissection for metastatic testis cancer.

  Christmas TJ, Smith GL, Kooner R.

  European Journal of Surgical Oncology. 1998 Aug;24(4):292-297. doi: 10.1016/s0748-7983(98)80009-7.

  View on PubMed →

• Wedge resection of pulmonary metastases from cancer of the testis or kidney using a vascular staple device.

  Christmas TJ, Smith GL, Kooner RS.

  British Journal of Urology. 1998 Jun;81(6):911-912. doi: 10.1046/j.1464-410x.1998.00698.x.

  View on PubMed →

Conference proceedings and abstracts

• Patient Response to Total Intravenous Sedation (TIVS) for Outpatient Ultrasound-Guided Prostate Biopsy.

  Raman A, Al-Sameraaii A, Thanigasalam R, Kooner R.

  Conference proceedings.

  View document →